SMS Pharmaceuticals Limited

NSEI:SMSPHARMA Stok Raporu

Piyasa değeri: ₹20.4b

SMS Pharmaceuticals Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

SMS Pharmaceuticals şirketinin toplam hissedar öz sermayesi ₹5.6B ve toplam borcu ₹2.9B olup, bu da borç-öz sermaye oranını 50.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹11.3B ve ₹5.7B dir. SMS Pharmaceuticals 'in FAVÖK'ü ₹955.7M faiz karşılama oranı 5 dur. Şirketin ₹90.7M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

50.6%

Borç/özkaynak oranı

₹2.85b

Borç

Faiz karşılama oranı5x
Nakit₹90.66m
Eşitlik₹5.64b
Toplam yükümlülükler₹5.71b
Toplam varlıklar₹11.35b

Son finansal sağlık güncellemeleri

Recent updates

Risks Still Elevated At These Prices As SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Shares Dive 25%

Nov 14
Risks Still Elevated At These Prices As SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Shares Dive 25%

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Sep 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40

Aug 22
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40

Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

Aug 20
Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Aug 08
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Jul 04
What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

Jun 21
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

Feb 29
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 24
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

Sep 11
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 28
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Jun 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

Sep 15
SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

Sep 01
SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 18
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

Mar 22
We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Jun 03
SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

Mar 08
Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

Feb 22
What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

Feb 08
The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 18
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SMSPHARMA 'nin kısa vadeli varlıkları ( ₹5.8B ) kısa vadeli yükümlülüklerini ( ₹3.8B ) aşıyor.

Uzun Vadeli Yükümlülükler: SMSPHARMA şirketinin kısa vadeli varlıkları ( ₹5.8B ) uzun vadeli yükümlülüklerini ( ₹2.0B ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SMSPHARMA 'nin net borç/öz sermaye oranı ( 49% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: SMSPHARMA şirketinin borç/öz sermaye oranı son 5 yılda 43.2% seviyesinden 50.6% seviyesine yükseldi.

Borç Kapsamı: SMSPHARMA 'nin borcu işletme nakit akışı ( 22.9% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: SMSPHARMA 'in borcuna ilişkin faiz ödemeleri EBIT ( 5 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin